AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 MyokardiaUniqureRa PharmaceuticalsArena PharmaceuticalsArQule
SymbolNASDAQ:MYOKNASDAQ:QURENASDAQ:RARXNASDAQ:ARNANASDAQ:ARQL
Price Information
Current Price$103.26$65.87$47.99$68.59$20.00
52 Week RangeBuyBuyHoldBuyHold
Beat the Market™ Rank
Overall Score1.21.50.71.31.0
Analysis Score3.53.51.02.41.2
Community Score2.62.92.42.42.6
Dividend Score0.00.00.00.00.0
Ownership Score0.01.00.01.01.0
Earnings & Valuation Score0.00.00.00.60.0
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyHold
Consensus Price Target$126.44$86.00$48.00$72.38$17.50
% Upside from Price Target22.45% upside30.56% upside0.02% upside5.52% upside-12.50% downside
Trade Information
Market Cap$4.80 billion$2.87 billion$2.27 billion$2.95 billion$2.42 billion
Beta2.331.291.051.392.49
Average Volume614,045422,8121,158,500696,8735,269,080
Sales & Book Value
Annual Revenue$33.56 million$7.28 million$3 million$806.43 million$25.76 million
Price / Sales143.63400.95757.114.2893.85
CashflowN/AN/AN/A$9.22 per shareN/A
Price / CashN/AN/AN/A7.44N/A
Book Value$8.79 per share$7.41 per share$5.56 per share$21.38 per share$0.72 per share
Price / Book11.758.898.633.2127.78
Profitability
Net Income$-276,210,000.00$-124,200,000.00$-102,690,000.00$397.55 million$-15,480,000.00
EPS($4.38)($3.11)($2.31)$7.69($0.16)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-1,991.17%N/A-5,727.22%-805.61%
Return on Equity (ROE)-51.01%-45.23%-44.61%-29.30%-33.10%
Return on Assets (ROA)-45.43%-31.35%-41.60%-26.95%-26.87%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.12%0.01%0.05%0.08%
Current Ratio7.83%12.89%14.78%18.67%8.27%
Quick Ratio7.83%12.89%14.79%18.67%8.27%
Ownership Information
Institutional Ownership PercentageN/A78.65%N/A88.04%74.63%
Insider Ownership Percentage5.20%2.66%4.30%2.73%13.80%
Miscellaneous
Employees1652127219436
Shares Outstanding46.68 million44.31 million47.33 million50.34 million120.87 million
Next Earnings Date8/5/2020 (Estimated)8/3/2020 (Estimated)N/A8/5/2020 (Estimated)N/A
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.